Media Room

 

 

Latest News Releases
Apr 24, 2018

Nektar Therapeutics (NASDAQ:NKTR) announced today that it has entered into a new clinical collaboration with Takeda Pharmaceutical Company Limited to evaluate Nektar's investigational medicine,...

Apr 15, 2018

Nektar Therapeutics (Nasdaq: NKTR) today announced that it is presenting new preclinical data for its immuno-oncology programs at the American Association for Cancer Research (AACR) Annual Meeting...

Apr 11, 2018

Nektar Therapeutics (Nasdaq: NKTR) today announced that it has initiated dosing patients in the Phase 1/2 REVEAL clinical study evaluating the efficacy and safety of the combination of...

More »

Multimedia Libraries
Media Contacts
Dan Budwick
Pure Communications, Inc.
[email protected]

More »

Follow Us on LinkedIn
Follow Us on Twitter


print email
 
 
Site Map Privacy Terms of Use Compliance Policy Trademarks Site Users Guide